NEW
YORK, July 9, 2024 /PRNewswire/ -- Today, Kaia
Health (Kaia) released the follow-up results of its landmark
randomized controlled trial—the Rise-uP study. The study revealed
superior long-term outcomes in clinical improvement and cost
savings for a digital-first treatment approach to lower back
pain.
In a study cohort of over 1,200 randomized participants—the
largest of its kind in the space—patients following Kaia's
digital-first treatment saw a significant reduction in pain as well
as positive improvements across physical function, mental health,
and overall reduction in the cost of care compared to standard
treatments after 12 months.
Key Findings:
Significant Pain Reduction: Participants using the Kaia
app experienced a 46% reduction in pain intensity, compared to a
24% reduction in the control group. This builds on the initial
three-month findings, which showed a 33% pain reduction in the Kaia
group compared to 14% in the control group.
Improved Functional Ability: Users of the Kaia app
achieved clinically significant improvements in functional ability
and physical wellbeing compared to the control group who showed
little to no change.
Mental Health Benefits: The study found lasting
improvements in mental health for Kaia app users, with participants
reporting reduced anxiety, depression, and stress levels as well as
improved mental well-being. Patients in the control group saw
deteriorating mental health trends over the same time period,
validating the importance of a holistic approach to managing
chronic pain and enhancing overall well-being.
Increased Patient Satisfaction: Participants in the Kaia
group reported higher levels of satisfaction with their treatment
compared to the control group.
Cost-Effectiveness: Participants in the Rise-uP group saw
an 81% decrease in overall healthcare costs compared to the control
group, primarily driven by a reduction in costs associated with
inpatient (hospital) treatment, medication costs, and incapacity
for work.
"We are pleased by the long-term results of the Rise-uP trial,
which confirm the impact of Kaia Health's digital therapy on pain
management and overall well-being," said Konstantin Mehl, Founder and CEO, Kaia Health. "These findings reinforce our
commitment to providing innovative, cost-effective, accessible
digital health solutions that improve the lives of people suffering
from chronic pain."
For more detailed information, please refer to the full report
here.
About Kaia Health:
Kaia Health is the world's largest
digital therapeutics company on a mission to empower millions of
people to live their healthiest lives. Kaia Health partners with
leading health plans, employers, and providers, covering nearly 65
million lives around the world. Kaia's evidence-based treatments,
covering a range of conditions, including MSK and COPD, are powered
by proprietary AI, motion analysis technology, and clinical
expertise. Kaia's app is designed to work on your smartphone or
tablet – delivering the most accessible, effective, and equitable
experience available. Across 20 clinical trials, Kaia Health has
demonstrated effectiveness and safety on par with traditional care
with as much as 80% reduction in cost, as recognized by the Program
Validation from the independent Validation Institute.
To learn more about Kaia Health, please visit
kaiahealth.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/kaia-healths-digital-therapy-shows-sustained-impact-on-pain-reduction-functional-ability-mental-health-and-cost-effectiveness-in-12-month-study-302192091.html
SOURCE Kaia Health